News
-
Funding meds in NZ would pay for itself: report
- Wed Sep 9
New analysis finds NZ would gain economic and fiscal returns by lifting medicines funding to OECD levels with benefits outweighing costs.
Read more -
RCA calls for survival target and faster access
- Wed Sep 9
Hot off the heels of a significant access win, RCA wants a national cancer survival target to increase the focus on low-survival cancers.
Read more -
How a PBAC ‘yes’ has become the new ‘no’
- Mon Sep 7
New analysis reveals positive PBAC decisions are rising, but workable listings aren’t signalling a PBAC ‘yes’ is no longer what it used to be.
Read more -
Which pharma has a new country leader?
- Mon Sep 7
Former Pfizer exec steps up to lead the Australian business of another company as other Australian executives also take on new responsibilities.
Read more -
Second nominee confirmed for MA Board
- Mon Sep 7
Another company leader confirms they will contest this year’s annual Board election with a number of eligible candidates still undecided.
Read more -
RCA picks up high-powered director
- Mon Sep 7
Former senior advisor to Health Minister Mark Butler, Jamie Snashall, joins the leading patient organisation’s Board at an interesting time.
Read more -
MA aims for the sky with big ticket PBS asks
- Fri Sep 4
Medicines Australia is going in guns blazing, calling for $47B in additional PBS investment and an end to 5- and 10-year anniversary price cuts.
Read more -
Big name nominates for industry board
- Fri Sep 4
A former board director confirms she will be standing again, but with so many of her predecessors failing, can she break the company curse?
Read more